Metabolic, structural and biochemical changes in diabetes and the development of heart failure
Diabetes contributes to the development of heart failure through various metabolic, structural
and biochemical changes. The presence of diabetes increases the risk for the development …
and biochemical changes. The presence of diabetes increases the risk for the development …
Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments
A Kuretu, C Arineitwe, M Mothibe, P Ngubane… - Frontiers in …, 2023 - frontiersin.org
Mitochondrial impairment has been associated with the development of insulin resistance,
the hallmark of type 2 diabetes mellitus (T2DM). However, the relationship between …
the hallmark of type 2 diabetes mellitus (T2DM). However, the relationship between …
Insulin Analogs and the Mode of Insulin Delivery: Recent Advances and Challenges
Diabetes is a medical condition associated with impaired glucose regulation caused either
due to insufficient insulin production or resistance to insulin (Type 2 diabetes, gestational …
due to insufficient insulin production or resistance to insulin (Type 2 diabetes, gestational …
[HTML][HTML] OCCURRENCE OF METFORMIN IN ENVIRONMENTAL WATER SAMPLES AND COMPARISON WITH CONSUMPTION DATA FROM A SURROUNDING …
LL Bai, J Gao, H Zhang, J Wang - Acta Endocrinologica (Bucharest …, 2023 - ncbi.nlm.nih.gov
Objective To determine the occurrence trends and possible environmental pollution sources
of metformin as an emerging micropollutant. Methods High-performance liquid …
of metformin as an emerging micropollutant. Methods High-performance liquid …
Evaluating the pharmacotherapy of tirzepatide in patients with type 2 diabetes: The consideration of systemic metabolism.
YC Lee, HH Chung - British Journal of Clinical …, 2023 - search.ebscohost.com
Dual GIP and GLP-1 receptor agonist Tirzepatide improves Beta-cell function and insulin
sensitivity in type 2 diabetes. Keywords: metabolic hormones; pharmacotherapy; systemic …
sensitivity in type 2 diabetes. Keywords: metabolic hormones; pharmacotherapy; systemic …
Can small molecule GLP-1 agonists be the next first-line drugs in type-2 diabetes mellitus?
R Seetharaman, S Pandit - Journal of Basic and Clinical Physiology …, 2024 - degruyter.com
Diabetes mellitus, especially type-2 diabetes mellitus (T2DM), has emerged as a significant
global health concern. According to the IDF Diabetes Atlas (2021), a staggering 10.5% of the …
global health concern. According to the IDF Diabetes Atlas (2021), a staggering 10.5% of the …